Blood Plasma Derivatives Market Is Expected To Exhibit 9.3% CAGR By 2023 | Fusion Health Care Pvt. Ltd., Biotest AG

High prevalence of different types of immunodeficiency disorders & hemophilia and upsurge in adoption of plasma derivative-based therapy have driven the growth of the market for blood plasma derivatives in the recent years.

Download Detailed COVID-19 Impact Sample Report at @ https://www.alliedmarketresearch.com/request-for-customization/656?reqfor=covid

The global blood plasma derivatives market held $25.98 billion in 2017 and is estimated to garner $44.33 billion by 2023, growing at a CAGR of 9.3% from 2017 to 2023.

Covid-19 scenario:

• There has been cancellation of Blood plasma drives amid lockdown and implementation of social distancing rules has decreased the number of blood donors across the globe.
• Governments have been appealing patients recovered from the Covid-19 to donate their plasma for infected patients.The report offers a detailed segmentation of the global blood plasma derivatives market based on type, application, end-user,and region.

Blood plasma is clear liquid component of blood in which red blood cells, white blood cells, and platelets are suspended. It plays a vital role in maintaining proper pH balance in the body and transporting nutrients throughout the body. It is composed of more than 100 different proteins, including albumin, fibrinogen, immunoglobulins, protease inhibitors, and clotting factors. Plasma derivatives are products that are derived from blood plasma on fractionation, and are widely used to treat variety of diseases.

Download Report Sample @ https://www.alliedmarketresearch.com/request-sample/656

The Immunoglobulin segment accounted for nearly half of the total revenue in 2017 and will maintain its dominance by 2023. This segment is expected to register the highest growth rate with a CAGR of 10% during the forecast period. The report also explores other types including Albumin, Factor VIII, Factor IX, Hyperimmune globulins, and others.

The global blood plasma derivatives market is segmented based on type, application, end user, and region.

Base on type, the market is segmented into albumin, factor VIII, factor IX, immunoglobulin, hyperimmune globulin, and others. Immunoglobulin segment accounted for the largest market share in 2016, and is expected to continue this trend throughout the forecast period. On the other hand, albumin segment is anticipated to grow at a significant CAGR of 9.4% during the forecast period.

Inquire before buying @ https://www.alliedmarketresearch.com/purchase-enquiry/656

Base on application, the market is categorized into hemophilia, hypogammaglobulinemia, immunodeficiency diseases, von Willebrand's Disease (vWD), and other applications. Immunodeficiency diseases segment accounted for the largest market share in 2016, whereas hemophilia segment is expected to register the highest growth rate during the forecast period.

Base on end user, the market is fragmented into hospitals, clinics, and other end users. Hospitals held the largest share of the market in 2016, whereas clinics segment is expected to register the highest growth rate during the forecast period.

North America was the leading revenue contributor to the global blood plasma derivatives market in 2016, and is expected to dominate the market during the forecast period. This is attributed to the early approval of plasma derivatives products and large number of fractionation plants in this region. However, Asia-Pacific is expected to grow at the highest CAGR during the study period, due to increase in affordability, surge in healthcare expenditure, and rise in awareness towards plasma derivatives.

To know more about the report, visit the website at @ https://www.alliedmarketresearch.com/blood-plasma-derivatives-market

The Major Key Players Are:

Grifols,S.A., SK Plasma Co., Ltd., Fusion Health Care Pvt. Ltd., Biotest AG, Green Cross Corporation, Baxter International Inc., LFB S.A., Octapharma AG, CSL Limited, and Shire Plc.

The Other Key Players Are:

China Biologic Products, Inc., Kedrion Biopharma, Inc., BDI Pharma, Inc., Bayer AG, and Hualan Biological Engineering, Inc.

Similar Reports:

Nanomedicine Market : https://www.pharmiweb.com/press-release/2020-02-11/nanomedicine-market-to-witness-increasing-growth-261-063-million-at-cagr-of-126-in-2023

Regenerative Medicine Market : https://www.pharmiweb.com/press-release/2020-02-11/regenerative-medicine-market-study-of-revenue-details-threats-in-the-target-market-and-forecast-by

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

About Us:

Allied Market Research (AMR) is a market research and business-consulting firm of Allied Analytics LLP, based in Portland, Oregon. AMR offers market research reports, business solutions, consulting services, and insights on markets across 11 industry verticals. Adopting extensive research methodologies, AMR is instrumental in helping its clients to make strategic business decisions and achieve sustainable growth in their market domains. We are equipped with skilled analysts and experts, and have a wide experience of working with many Fortune 500 companies and small & medium enterprises.

This release was published on openPR.